Novamind anticipates trading on the CSE under the symbol ‘NM’ on January 5, 2021
TORONTO, ON / ACCESSWIRE / December 31, 2020 / Novamind Inc. (“Novamind” or the “Company“), a leading mental health company specialized in psychedelic-assisted psychotherapy, will present at the SNN Network Canada Virtual Event on Thursday, January 7 at 4:30 PM EST. Yaron Conforti, Novamind’s CEO will host the presentation and answer questions from investors. The presentation will provide an overview of Novamind’s clinical and research infrastructure for psychedelic medicine as well as cover the Company’s public listing on the Canadian Securities Exchange.
To access the live presentation, please use the following details:
SNN Network Canada Virtual Event 2021
Date: Thursday, January 7, 2021
Time: 4:30 PM Eastern Time
To book a one-on-one investor meeting with Novamind or to watch the Company’s presentation, please register for the virtual event here: www.canada.snn.network/signup
For those unable to attend the live presentation, all company presentation webcasts will be available directly on the conference event platform on this link under the tab “Agenda”: www.canada.snn.network/agenda
Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca.
SNN.Network is your multimedia financial news platform for discovery, transparency and due diligence. This is your one-stop hub to find new investment ideas, check in on watchlist, gather the most up-to-date information on the Small-, Micro-, Nano-Cap market with the goal to help you towards achieving your wealth generation goals. Follow the companies you want to know more about; read and watch content from your favorite finance and investing influencers; create your own watchlist and screen for ideas you’re interested in; find out about investor conferences you want to attend – all here on SNN.Network.
Yaron Conforti, CEO and Director
Telephone: +1 (647) 953 9512
Bill Mitoulas, Investor Relations
Email: [email protected]
This news release contains forward-looking statements. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations including the risks detailed from time to time in the Company’s public disclosure. The reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable laws.
SOURCE: Novamind Inc.
View source version on accesswire.com: